The off-label use of JAK inhibitors to treat JDM is common in pediatric rheumatology, with barriers to use including limited clinical trial data and insurance approval.

Letybo (letibotulinumtoxinA-wlbg) is now available for the temporary improvement in the appearance of moderate to severe ...

Dr Peter Marks is resigning as director of the FDA's Center for Biologics Evaluation and Research by April 5 due to objections to RFK Jr.

Several characteristics, including BMI and Charlson Comorbidity Index, were associated with super response to biologics in patients with psoriasis.

Rates of fatal drug overdoses are higher than expected in most states, despite a 14.5% decrease in the year leading up to June 2024.

The US government's termination of funding will affect research on HIV prevention, cancer, youth suicide, bone health, and more.

Emrosi (minocycline hydrochloride extended-release capsules) is now available for the treatment of inflammatory lesions (papules and pustules) of rosacea in adults.

Some monotherapies have significant differences in efficacy for vitiligo, whereas other modalities have similar efficacy between therapies.

Alpha-gal syndrome, a severe and life-threatening allergy to red meat, has been linked to tick bites in Maine and Washington.

The heads of five different offices, among other CDC officials, resigned following the nomination of Susan Monarez for director.

Alopecia areata incidence was highest in patients in North America, Southeast Asia, and Australia, as well as in women and those aged 30 to 34 years.

Janus kinase (JAK) inhibitors are associated with an increased risk for lung cancer but not overall cancer among older patients in the United States with rheumatoid arthritis (RA), according to study ...